Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
The Journal of Infectious Diseases|October 2, 2002
Mucosal immunization with inactivated human immunodeficiency virus plus CpG oligodeoxynucleotides induces genital immune responses and protection against intravaginal challengeNancy Dumais, Amy Patrick, Ronald B Moss, et al.
Immunology|August 3, 2002
Maternal and newborn immunization with a human immunodeficiency virus-1 immunogen in a rodent modelRonald B Moss, Jay R Savary, Jocelyn P Diveley, et al.
Vaccine|May 30, 2002
Generation of Th1 immune responses to inactivated, gp120-depleted HIV-1 in mice with a dominant Th2 biased immune profile via immunostimulatory [correction of imunostimulatory] oligonucleotides--relevance to AIDS vaccines in developing countriesMila Ayash-Rashkovsky, Ziva Weisman, Jocelyn Diveley, et al.
The Journal of Infectious Diseases|October 10, 2012
A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infectionRonald B Moss, Carrie Hansen, Rebecca L Sanders, et al.
Antiviral Therapy|July 3, 2015
Treatment of resistant influenza virus infection in a hospitalized patient with cystic fibrosis with DAS181, a host-directed antiviralFernanda P Silveira, Rima Abdel-Massih, Tatiana Bogdanovich, et al.
Plos One|June 17, 2020
Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor levelRonald B Moss, Meghan McCabe Pryor, Rebecca Baillie, et al.
Expert Opinion on Biological Therapy|December 2, 2004
Th1/Th2 cells in inflammatory disease states: therapeutic implicationsRonald B Moss, Thomas Moll, Mohammad El-Kalay, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 19, 2005
Enhanced HIV-1 specific immune response by CpG ODN and HIV-1 immunogen-pulsed dendritic cells confers protection in the Trimera murine model of HIV-1 infectionMila Ayash-Rashkovsky, Gadi Borkow, Heather L Davis, et al.
Vaccine|February 1, 2003
HIV-specific immunity during structured antiviral drug treatment interruptionRonald B Moss, Carolyn Brandt, Wieslawa K Giermakowska, et al.
The Journal of Allergy and Clinical Immunology|December 13, 2005
Anti-T-cell Ig and mucin domain-containing protein 1 antibody decreases TH2 airway inflammation in a mouse model of asthmaJeffrey A Encinas, Edith M Janssen, David B Weiner, et al.
Pageof 3